Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;70(1):47-55.
doi: 10.1177/0003319718780772. Epub 2018 Jun 7.

Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study

Affiliations

Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study

Abayomi Oyenuga et al. Angiology. 2019 Jan.

Abstract

Galectin-3 is a β-galactoside-binding lectin that plays a role in the regulation of several conditions that are associated with atherosclerosis. The goal of this cross-sectional study was to assess the association of plasma galectin-3 concentrations with sonographic measures of carotid atherosclerosis in the Atherosclerosis Risk in Communities study. Linear regression was used to determine the difference and 95% confidence intervals (CIs) for carotid intima-media thickness (cIMT) by categorical and continuous representations of galectin-3. Logistic regression was used to determine the odds ratio and 95% CI, separately, for dichotomized cIMT (75th percentile = 0.9 mm) and carotid plaque and/or shadowing. Compared to those in the first quintile of galectin-3, those in the fifth quintile of galectin-3 level had higher cIMT (mean difference: 0.020 mm after multivariable adjustment; P trend = .04). Moreover, compared to those in the lowest galectin-3 quintile, those in the highest galectin-3 quintile had higher odds of carotid plaque/and or shadowing (odds ratio 1.13 after multivariable adjustment; P trend = .014). Higher levels of galectin-3 are associated with greater carotid atherosclerosis. Our findings provide support for the role of inflammatory biomarkers in the pathogenesis of atherosclerosis and suggest galectin-3 as a possible target for intervention in the prevention or management of atherosclerotic disease.

Keywords: ARIC; atherosclerosis; carotid intima–media thickness; galectin-3; plaque; shadowing.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests

Financial disclosure for Christie M. Ballantyne, MD:

Grant/research support: Abbott Diagnostics, Roche Diagnostics (to institution, not individual).

Consultant: Abbott Diagnostics, Roche Diagnostics.

Patent pending: Provisional patent (patent no. 61721475) entitled “Biomarkers to Improve Prediction of Heart Failure Risk” filed by Baylor College of Medicine and Roche.

The other co-authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Eligibility Determination for Galectin-3 and Atherosclerosis, ARIC 1996–1998.
Figure 2.
Figure 2.
A. Difference (SE) in Mean Carotid IMT (mm). B. Odds Ratios (95% CI) for Mean Carotid IMT > 75th Percentile. C. Odds Ratios (95% CI) for Carotid Plaque and/or shadowing, in Relation to Plasma Galectin-3 Quintiles, ARIC 1996–1998. *Graphs Shown are for Model 1.

Comment in

References

    1. Roquer J, Ois A. Atherosclerotic Burden and Mortality In: Preedy VR, Watson RR, editors. Handbook of Disease Burdens and Quality of Life Measures. New York, NY: Springer New York; 2010, p. 899–918.
    1. Barquera S, Pedroza-Tobias A, Medina C, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res. 2015;46;328–38. - PubMed
    1. Falk E Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47(8 Suppl):C7–12. - PubMed
    1. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204–12. - PubMed
    1. Ross R. Atherosclerosis — An inflammatory disease. N Engl J Med. 1999;340:115–26. - PubMed